James O'Brien
2021
In 2021, James O'Brien earned a total compensation of $1M as Chief Financial Officer at COGNITION THERAPEUTICS, a 148% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $155,000 |
|---|---|
| Option Awards | $522,787 |
| Salary | $348,769 |
| Other | $11,600 |
| Total | $1,038,156 |
O'Brien received $522.8K in option awards, accounting for 50% of the total pay in 2021.
O'Brien also received $155K in non-equity incentive plan, $348.8K in salary and $11.6K in other compensation.
Rankings
In 2021, James O'Brien's compensation ranked 8,673rd out of 12,415 executives tracked by ExecPay. In other words, O'Brien earned more than 30.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,673 out of 12,415 | 30th |
Division Manufacturing | 3,849 out of 5,508 | 30th |
Major group Chemicals And Allied Products | 1,700 out of 2,378 | 29th |
Industry group Drugs | 1,513 out of 2,099 | 28th |
Industry Biological Products, Except Diagnostic Substances | 330 out of 449 | 27th |
Source: SEC filing on April 25, 2022.
O'Brien's colleagues
We found two more compensation records of executives who worked with James O'Brien at COGNITION THERAPEUTICS in 2021.